Germany vs Hungary: The number of people with susceptibility test result for rifampicin
Germany
83.72
in 2021
Hungary
84.02
in 2021
Germany rank
89th
Hungary rank
88th
The number of people with susceptibility test result for rifampicin over time
- Germany
- Hungary
How they compare
Hungary currently reports 84.02 against 83.72 in Germany, a difference of 0.3.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Hungary ahead.
Germany ranks 89th and Hungary ranks 88th of 146 countries.
Across the 2 decades both report, Germany averaged higher in 1 and Hungary in 1.
Head to head by decade
| Decade | Germany | Hungary | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 87.11 | 90.43 | 3.32 | Hungary |
| 2020s | 84.9 | 84.63 | 0.2674 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Germany or Hungary?
- Hungary, at 84.02 against 83.72 in Germany as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Germany and Hungary?
- 0.3, with Hungary ahead.
- How many years of comparable data are there for Germany and Hungary?
- 5 years are reported by both, from 2017 to 2021.
- How do Germany and Hungary rank globally for the number of people with susceptibility test result for rifampicin?
- Germany ranks 89th and Hungary ranks 88th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.